Authors


Renee Dowling

Latest:

Everything you need to know about medical coding and billing audits

Through medical claims audits, the practice can help protected itself against fraudulent billing activity and claims.


Nilay Gandhi, MD

Latest:

Overview of Advanced/Metastatic Prostate Cancer

In the first article of this series, Nilay Gandhi, MD, explains the treatment and management of patients with advanced/metastatic prostate cancer and details the options for androgen deprivation therapy.


Lauren Hanson

Latest:

Tips for physicians to improve work-life balance

Overworking has become the norm, but that doesn’t mean it should be.


Pharmacy Times Staff

Latest:

Case report details spontaneous bladder rupture caused by herpes zoster–associated urinary retention

Although cases of acute urinary retention and defecation caused by herpes zoster in the sacral area have been reported, no clinical cases about spontaneous bladder rupture have been previously published, according to the authors.


Jim Lu, MD, PhD

Latest:

Molecular diagnostic practice in prostate and bladder cancers

"Liquid biopsy analysis provides a noninvasive and facile tool for early detection, diagnosis, and recurrence surveillance of urological cancer," writes Jim Lu, MD, PhD.


Daniel A. Barocas, MD, MPH, FACS

Latest:

Strategies to mitigate impact of intravenous ICM shortage

"The global shortage of ICM has necessitated rapid adaptation of workflows and clinical pathways, which are particularly important for practicing urologists who are evaluating patients for hematuria," write Yair Lotan, MD, and colleagues.


Michelle Semins, MD

Latest:

Future Perspectives in the Treatment of Patients With Urinary Stones

Drs Bechis and Semins discuss future developments in urinary stone management, emphasizing the potential for improved vacuum aspiration devices, combined intravenous and PCNL surgeries, and the hope for medications to dissolve stones.


Dave S. Gilreath, CFP

Latest:

Money Matters: Informing your perspective on the bear market

No matter what your age or risk tolerance, investing is a lot easier and likely more successful if your perspective is informed by market history.


Shane Peng, MD

Latest:

Expert explains challenges of telehealth

Although much of the discourse around telehealth rightfully focuses on its benefits, the potential drawbacks and limitations are often glossed over, particularly around provider burden.


Sam S. Chang, MD, MBA

Latest:

Forward Looking NMIBC Treatment Advancements and Needs in 2024

In this final episode, panelists conclude with reflections on the significant progress made in treating NMIBC over the past decade, particularly in the last 5 years. Looking ahead to 2024, experts in urology express excitement about investigational treatments (ie, cretostimogene grenadenorepvec and UGN 102), the potential for personalized medicine, emphasizing the need to understand molecular characteristics of the disease for better treatment customization. The session also highlights the importance of balancing quality of life with effective treatment strategies, and the prospect of utilizing emerging therapies early in the disease process.


Allen Alishahi

Latest:

Ensuring operational continuity is critical with healthcare data breaches

With healthcare data breaches approaching a boiling point, care providers need to adopt an approach that prioritizes operational continuity.



Petros Grivas, MD, PhD

Latest:

Frontline Therapy for Non-Metastatic Muscle-Invasive Bladder Cancer

Frontline treatment approaches recommended by urologists and medical oncologists for patients with non-metastatic muscle-invasive bladder cancer.


Tullika Garg, MD, MPH, FACS

Latest:

Managing aging and frailty in the urologic cancer population

Increasing numbers of older patients with cancer necessitates adoption of an age-friendly approach to cancer care.


Jordyn Sava

Latest:

Dr. Clara Hwang discusses study of precision medicine disparities in prostate cancer

Clara Hwang, MD, is the lead author of the study, “Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer.”



Dylann Cohn-Emery

Latest:

Lenvatinib/pembrolizumab compares favorably with frontline standards in renal cell carcinoma

“Combination therapy with lenvatinib plus pembrolizumab provides a comparable OS, and a trend of improvement in PFS and response outcomes, compared with most current global SOC therapies for treatment-naïve patients with advanced renal cell carcinoma,” the study authors wrote.


Jacob E. Tallman, MD

Latest:

Update on advanced imaging in prostate cancer

Advances allow for more accurate detection of metastatic disease.



Kamal S. Pohar, MD

Latest:

Lymph nodes in bladder cancer: Past, present, and future

"Based on the LEA and S1011 trials, it has become clear that patients do not benefit from an extended LND, and a standard bilateral pelvic LND is the standard of care," write Amir Soltani-Tehrani, MD, and Kamal S. Pohar, MD.


Daniel Allan Hamstra, MD, PhD, FASTRO, FASCO

Latest:

Ongoing Studies Investigating Rectal Spacer Benefits in Patients With Prostate Cancer Undergoing Radiation Therapy

Dr Daniel Allan Hamstra highlights ongoing and planned trials investigating rectal spacers in patients with prostate cancer undergoing radiation therapy that he hopes will provide more data on toxicity reduction and preservation of sexual function.


Ammad Khan, MD

Latest:

PARP inhibitors: Treating mCRPC from a genetic basis

Treatments provide a targeted therapeutic strategy for metastatic castration-resistant prostate cancer.


Caitlin Shepherd, MD

Latest:

How to implement an ERAS pathway in your urology practice

Program encompasses patient counseling, anesthetic planning, and early mobilization.


AACU

Latest:

AACU shines a spotlight on reimbursement with prior policy advocacy & its upcoming 3/19 Congressman Murphy (R-NC) webinar

The AACU is excited to announce its March 19, 2024 8PM EST webinar with Congressman Murphy.


Mary K. Samplaski, MD
Mary K. Samplaski, MD

Latest:

Expert Forum: Fertility after exogenous testosterone replacement

Treatment of azoospermia after exogenous testosterone use may require aggressive medical therapy, according to Kelli Gross, MD.


Hiten D. Patel, MD, MPH

Latest:

Distinguishing between malignant and benign renal masses

"Augmented biopsy-based and noninvasive options are available to reduce benign resection rates of renal tumors with the consideration of PEER and 99mTc-sestamibi SPECT/CT," writes Hiten D. Patel, MD, MPH.


Daniel P. Petrylak, MD

Latest:

Optimization of Genetic Testing for mCRPC

Jason M. Hafron, MD, CMO, and Oliver Sartor, MD, share their approach for the optimal management of mCRPC through genetic testing.


Daniel D. Rhoads, MD

Latest:

Diagnostic stewardship for urinary tract infection: A snapshot of the expert guidance

Urinary tract infections (UTIs) are among the most common human infections. But the urine culture, the cornerstone for laboratory diagnosis of UTI, is imperfect.


Thomas Lowrey, MD

Latest:

How to implement an ERAS pathway in your urology practice

Program encompasses patient counseling, anesthetic planning, and early mobilization.


Roger Dmochowski, MD, MA (Conflict Management and Resolution), MMHC, FACS

Latest:

The American Board of Urology: Considerations for the urologist in career transitions

"The ABU continues to reevaluate all policies related to diplomates. As medical practice continues to evolve in United States, and these changes affect the practitioners of medicine, likely further changes will be necessary in board certification procedures," writes Roger Dmochowski, MD, MA (Conflict Management and Resolution), MMHC, FACS.

© 2024 MJH Life Sciences

All rights reserved.